Breast Flashcards
Breast cancer RFx
- FEMALE
- Increased OESTROGEN (early menarche + late menopase)
- More glandular tissue
- OBESITY
- ALCOHOL (metabolised into carcinogen) / SMOKING
- 1ST DEGREE RELATIVE (FHx)
cOCP + HRT (esp combined)
Breast Cancer pathophys
BRCA (BReast CAncer) gene = tumour suppressor -> mutation = cancer
- BRCA1 (chromosome 17)
- 70% breast cancer by 80 + 50% ovarian
- bowel + prostate
- BRCA2 (chromosome 13)
- 60% breast by 80 + 20% ovarian
Types of breast cancer
- Ductal carcnioma in situ
- lobular carcinoma in situ
- Invasive ductal carcinoma (no specific type - NST)
- Invasive lobular carcinoma
- Inflam breast cancer
- Paget’s disease of Nipple
Rare:
Medullary breast cancer
Mucinous breast cancer
Tubular breast cancer
+ more
Breast Cancer screening
NHS -> MAMMOGRAM every 3 YEARS for everyone 50-70 Y/O (post-menopausal typically)
Then call back + thermography if something seems unusual
Can also use a MRI in complex cases (useful in ppl with implants too)
Downsides to breast cancer screening
- Anxiety and stress
- Exposure to radiation, with a very small risk of causing breast cancer
- Missing cancer, leading to false reassurance
- Unnecessary further tests or treatment where findings would not have otherwise caused harm
- Expensive
But benefits outweigh risks usually
Which people are high-risk for breast cancer
People with significant FHx:
- 1st degree relative under 40
- 1st degree male relative
- 1st degree relative with bilateral breast cancer diagnosed under 50
- 2 or more 1st degree relatives
Interventions for women at high-risk of breast cancer
Secondary care clinic or specialist genetic clinic
- can get genetic testing (need genetic and pre-test counselling)
Get ANNUAL mammogram
May use CHEMOPREVENTION:
- Tamoxifen (premenopause)
- Anastrozole (postmenopause - CI if severe osteoporosis)
Risk -reducing bilateral mastectomy or oophrectomy (less common)
Clinical features suggestive of breast cancer
-
Lumps: HARD, IRREGULAR, PAINLESS or FIXED
- may be tethered to skin/chest wall
- NIPPLE RETRACTION
- Skin dimpling (peau d’orange)
- LYMPHADENOPATHY (esp axilla)
When is a 2 week wait referral recommended for breast cancer
- An unexplained breast lump in patients aged 30 or above
- Unilateral nipple changes in patients aged 50 or above (discharge, retraction or other changes)
Consider for:
- unexplained axilla lump in over 30s
- indicative skin changes
What is the algorithm for once someone gets a 2 week referral for breast ca
Triple diagnostic assessment:
- Clinical assessment (history and examination)
- Imaging (ultrasound or mammography)
- also of lymphnodes in the axilla + to guide biopsy of any abnormal nodes - Biopsy (fine needle aspiration or core biopsy)
USS vs mammography for breast cancer
- USS better for younger women (have more glandular tissue)
- good to distinguish between solid and cystic
- Mammogram better for older
- can pick up calcifications
Can also use MRI for screening high-risk or to further assess tumour dimensions
What is a sentinal node biopsy
A sentinal node is the first node in the lymphatic drainage of a tumour area
Injecting isotope contrast and dye into tumour area highlights the sentinal node. A biopsy can be taken and nodes removed if cancer found.
Done if initial USS shows no abnormal nodes
Breast Cancer Receptors
Oestrogen receptors (ER)
Progesterone receptors (PR)
Human epidermal growth factor (HER2)
Treatment depends on which is present. Cancer can be triple negative = worse prognosis,
Where can breast cancer metastesise
Anywhere in body. But Main sides are:
- LUNGS
- LIVER
- BRAIN
- BONES
Breast Cancer Tx
- Surgery
- Breast conservation + radiotherapy
- Mastectomy
- Axillary clearance (SE: chronic Lymphoedema)
- Adjuvent Radiotherapy (SE: fatigue, irritation, fibrosis, shrinking)
- Chemo (typically if sensitive):
- Neoadjuvant
- Adjuvant
- treat mets/recurrance
- Hormone therapy (for 5-10 years)
- Tamoxifen, goserelin (- a GnRH agonist) (premonopause) (SE: risk of endometrial cancer)
- Aromatase inhib (postmenopause)
- Adjuvent bisphosphonates in postmenopausal women
Tamoxifen MOA
Selective oestrogen receptor modulator (SERM)
Blocks oestrogen receptors in breast tissue, and stimulates oestrogen receptors in the uterus and bones
helps prevent osteoporosis, but it does increase the risk of endometrial cancer
Aromatase inhib MOA
Aromatase is found in fat - converts androgens to oestrogen -> primary oestrogen sourse post-menopause
Inhibs stop oestrogen production in fat